AGA Clinical Practice Update on Alpha-Gal Syndrome for the GI Clinician: Commentary
Clinical Gastroenterology and Hepatology · 2023-04 · 21 (4) · 891-896
DOI: 10.1016/j.cgh.2022.12.035 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-04. Verfasst von Sarah K McGill und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: mcgills@me…. Hauptthemen laut MEDLINE: Food Hypersensitivity, Gastrointestinal Diseases, Gastroenterology. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
DESCRIPTION: Alpha-gal syndrome is an emerging allergy first described in the early 2000s. The allergy can cause anaphylaxis, gastrointestinal (GI) symptoms, and skin changes one to several hours after ingestion of mammalian products. A GI phenotype that is increasingly recognized manifests with nonspecific symptoms like abdominal pain, diarrhea, nausea or vomiting without predominant skin, respiratory or circulatory symptoms. Though the syndrome has been reported on all continents except Antarctica, in the United States most reports are within the range of the Lone Star tick, extending from New York and Iowa to Texas and Florida. The purpose of this AGA Clinical Practice Update (CPU) Commentary is to increase awareness among gastroenterologists about the presentation and management of alpha-gal syndrome. METHODS: This CPU commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the CPUC and external peer review through standard procedures of Clinical Gastroenterology and Hepatology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors. Formal ratings regarding the quality of evidence or strength of the presented considerations were not included since systematic reviews were not performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: mcgills@med.unc.edu.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Florida; Division of Gastroenterology and Hepatology, American University of Beirut, Beirut, Lebanon.
- Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville, Virginia.
Förderung
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
McGill, S. K., Hashash, J. G., & Platts-Mills, T. A. (2023). AGA Clinical Practice Update on Alpha-Gal Syndrome for the GI Clinician: Commentary. Clinical Gastroenterology and Hepatology, 21(4), 891-896. https://doi.org/10.1016/j.cgh.2022.12.035
Vancouver
McGill SK, Hashash JG, Platts-Mills TA. AGA Clinical Practice Update on Alpha-Gal Syndrome for the GI Clinician: Commentary. Clinical Gastroenterology and Hepatology. 2023;21(4):891-896. doi:10.1016/j.cgh.2022.12.035
BibTeX
@article{McGill2023,
author = {McGill, Sarah K and Hashash, Jana G and Platts-Mills, Thomas A},
title = {AGA Clinical Practice Update on Alpha-Gal Syndrome for the GI Clinician: Commentary},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
volume = {21},
number = {4},
pages = {891--896},
doi = {10.1016/j.cgh.2022.12.035}
}
EUVIMED